Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin - Wikidata - wikimedia - TriplyDB

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

http://www.wikidata.org/entity/Q30983984

about

Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6 Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutinin SERPINA4 is a novel independent prognostic indicator and a potential therapeutic target for colorectal cancer.Kallistatin modulates immune cells and confers anti-inflammatory response to protect mice from group A streptococcal infection.Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells.Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma Kallistatin suppresses cancer development by multi-factorial actions.Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 α in lung tumor.Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression.Protective Role of Kallistatin in Vascular and Organ Injury.Resveratrol inhibits LPS-induced epithelial-mesenchymal transition in mouse melanoma model.Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.

P2860

Q33939375-2A434F17-22DB-4B36-99E2-86253FD6B43A Q35960792-E189598E-4D89-455D-889A-C5DD05F5840C Q37215516-89E9E77A-FA54-4CDF-94A8-CF4298370D42 Q37263454-B6735591-FC82-4BBA-A192-F69DD54CCBFB Q37370247-C4078F45-E8CB-45D7-9DB0-9321616ED00F Q37428849-C481E3EC-6B8B-4E9D-A09C-57683089E8A1 Q37466518-7E7F08BA-3730-4B48-B172-8C075CB8FDA1 Q37623620-32ECFF9A-6513-4901-99E2-2FD537E68F5E Q39252905-CCC748B2-EB22-4E2B-A3F5-075EDF202C79 Q39396910-F7680EF1-DDE0-4E1B-8869-01F368BE89C8 Q39458426-07707371-622D-472F-867D-3F3ACFB7AF91 Q42360588-97948AFB-856B-45FD-A2D3-6209269F2B8B Q42721176-9316B434-A35A-4AB1-A71D-B793EDFC55B1 Q51301114-AFC04F5A-5B81-4A89-8D08-B6BD76F08B24

P2860

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

http://www.wikidata.org/entity/Q30983984

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

@ast

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

@en

type

label

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

@ast

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

@en

prefLabel

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

@ast

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

@en

P1433

Q30983984-2B6FD3FD-B3EA-410C-9EB4-2E66DFA5F865

P1476

Q30983984-F830E0B1-439A-4A67-B570-90FB9A6737B0

P2093

Q30983984-09119FA6-200F-4BA4-803D-65FD4C68D0F5

Q30983984-0AFD5053-C783-40E5-967E-2B920CB494E1

Q30983984-21CB84CF-F5AD-41BF-BF6A-288474340292

Q30983984-7580B902-2C39-45CA-A70A-A7C3A0B88DA8

Q30983984-A714EDDC-57CE-4507-BF9E-EC3A4790B830

Q30983984-B710D2E0-98F8-4DE3-A807-88F368463321

Q30983984-BE113886-A575-4F35-AC6B-A4C59C85E036

Q30983984-CB479135-12D8-4145-948F-55A972096554

Q30983984-D48C1D4B-5ADD-4E97-8D3D-94DBCC90DC5D

Q30983984-F92B67B5-D011-4BC8-8381-DDA8C9F78A58

P2860

Q30983984-076053D7-7DC3-4FDE-988D-57E4BF85AECC

Q30983984-095379B3-D75C-4112-B6E9-1262EB86C54C

Q30983984-113F0445-CD62-44E5-8247-B915191CD614

Q30983984-14BD6DD8-5E31-40EA-A3C0-2530FE0C296C

Q30983984-180BA640-3E4F-4BE4-9EF0-3CBD2DD58051

Q30983984-1AD79940-702F-4B86-913F-B70AF7DF90A6

Q30983984-221FCF80-BD6C-4118-8ACE-DD0B4A8E1956

Q30983984-2FBF17B2-75DE-45B7-9521-77FA47339EAF

Q30983984-32C43334-5780-4869-AF90-94F65624B0E3

Q30983984-4CD8D660-E853-4375-A365-263CF7785F1C

P2888

Q30983984-DBBF83B8-57FF-457D-A310-B3A98E181583

P304

Q30983984-BCB0B861-23B7-4F9C-8B70-EEF15755E938

P31

Q30983984-6A906094-B4DE-402C-BCD6-9D86B9A05CC4

P356

Q30983984-C6D9803F-4D5A-4612-A57B-0A6696166EA0

P407

Q30983984-3DA9B8B6-C162-4E25-8614-DBDFB9892A5E

P478

Q30983984-5EA03E97-5373-43C6-8F07-6690B9132DE7

P50

Q30983984-5A75F767-D3E3-4642-90AF-5CABA635191E

P577

Q30983984-0777AEF2-FE80-4485-9490-8BE28FAC4036

P5875

Q30983984-E1A8942E-B853-439E-89E6-8B46ABB99EFF

P6179

Q30983984-1A8B0D1E-4717-4A91-AFF5-FAA7770AD68A

P698

Q30983984-213711A2-BCD8-46D0-9184-44E043E96AA5

P932

Q30983984-A6EB6D81-1872-4BDF-9BE7-744BAF6B0F44

P356

1471-2407-10-245

P1433

P1476

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin

@en

P2093

Ai-Li Shiau

http://www.w3.org/2001/XMLSchema#string

Che-Hsin Lee

http://www.w3.org/2001/XMLSchema#string

Chih-Jui Chang

http://www.w3.org/2001/XMLSchema#string

Chrong-Reen Wang

http://www.w3.org/2001/XMLSchema#string

Jeng-Long Hsieh

http://www.w3.org/2001/XMLSchema#string

Julie Chao

http://www.w3.org/2001/XMLSchema#string

Lee Chao

http://www.w3.org/2001/XMLSchema#string

Meng-Ya Chang

http://www.w3.org/2001/XMLSchema#string

Min-Li Teo

http://www.w3.org/2001/XMLSchema#string

Shin-Yao Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Modes of resistance to anti-angiogenic therapy

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

The chemokine system in diverse forms of macrophage activation and polarization

Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation.

Kallistatin is a new inhibitor of angiogenesis and tumor growth.

Molecular cloning, sequence analysis, and chromosomal localization of the human protease inhibitor 4 (kallistatin) gene (PI4).

Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease.

Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.

Kallikrein-binding protein inhibits growth of gastric carcinoma by reducing vascular endothelial growth factor production and angiogenesis.

Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas.

P2888

1471-2407-10-245

P304

245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-10-245

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44637494

http://www.w3.org/2001/XMLSchema#string

P6179

1024710607

http://www.w3.org/2001/XMLSchema#string

P698

20509975

http://www.w3.org/2001/XMLSchema#string

P932

2893111

http://www.w3.org/2001/XMLSchema#string